Disclaimer: This content is for informational and educational purposes only and should not be construed as financial or investment advice. Always do your own research and consult a licensed financial advisor before making investment decisions.

Disclosure: The author holds a long position in AMPX.

← Back to Free Index

AMPX

Analysis as of: 2026-05-28

Amprius Technologies, Inc.

Amprius develops and sells high-energy silicon-anode lithium-ion battery cells for drones, defense, aviation and light electric mobility.

aerospace defense energy hardware transportation

On Yahoo Finance ...

Jump to: Summary • Analysis • Opportunity • Risk • Trends • LE Structure • Third Party Analyst Consensus

Summary

Real Battery Edge, Expensive Starting Point

The chemistry is good enough to win real programs, and recent execution improved confidence that demand is not hypothetical. The investment question is now whether partner-led scale and above-cell value capture can outrun dilution and multiple compression.

Analysis

Thesis

Amprius has a real silicon-anode edge in weight-sensitive batteries, and if it turns current drone, defense and mobility wins into repeat partner-manufactured volume while moving some value capture into compliance-ready modules and support, revenue can scale non-linearly even though the stock's hardware multiple should compress from today's premium level.

Last Economy Alignment

Cheap cognition should expand drones, defense autonomy and robotics, and Amprius sells a mission-critical physical input with qualification stickiness rather than a software layer at risk of commoditization. The score stops short of higher because scaled manufacturing is not fully controlled and chemistry substitution remains a real threat.

Upgrade to Allocator to also access: Thesis Critique

Opportunity Outlook

Average Implied 5-Year Multiple

2.1x (from 5 most recent analyses)

Reasoning

The upside is operational rather than valuation-driven. If Amprius converts real drone, defense and mobility wins into repeat partner-manufactured volume, and adds some module and service revenue, the business can grow fast enough that shareholders still earn solid returns even as the current premium hardware multiple compresses toward a mature specialized-supplier level.

Upgrade to Allocator to also access: Simplified Opportunity Explanation

Risk Assessment

Overall Risk Summary

The product risk is lower than the business-model risk. Amprius now has to prove that chemistry leadership survives outsourced manufacturing, qualification-heavy adoption and concentrated counterparties. If partner quality, domestic compliance or repeat-program conversion slip, the current premium valuation can overwhelm real revenue growth.

Upgrade to Allocator to also access: Tech Maturity Risk Score, Adoption Timing Risk Score, Moat Strength Risk Score, Capital Needs Risk Score, Regulatory Risk Score, Execution Risk Score, Concentration Risk Score, Unit Economics Risk Score, Valuation Risk Score, Macro Sensitivity Risk Score

Trends

Key Changes

On May 19, 2026, Amprius said its cells already power Matternet's M2 fleet and set an early-2027 volume-readiness target for Matternet's next-generation platform.
On May 19, 2026, the warrant exchange closed: 7.1 million public warrants were retired in exchange for 2.7 million shares, reducing overhang but increasing share count.
Since May 19, 2026, there has been no fresh operating disclosure; the near-term debate is now shipment, margin and guide delivery rather than another new design win.

Thesis update

Core thesis is unchanged: real chemistry edge, now with slightly better commercial proof. The update is higher confidence in demand visibility, not a new business model.

Forecast update

Recent execution and program news improved conviction, but much of that benefit was absorbed by the stock's rerating, limiting incremental upside expansion.

Upgrade to Builder to also access: Future Considerations

Last Economy Structure

AI Industrial Score

0.47

They sell a scarce battery that matters when drones and robots need more range from the same weight, and defense sourcing rules can make them a trusted supplier instead of just another cell vendor. The upside comes from more qualified programs feeding repeat orders; the risk is that manufacturing partners or bigger battery companies capture the scale benefits first.

Upgrade to Reader to also access: Score Decomposition, Confidence Level

Upgrade to Allocator to also access: Obsolescence Vectors, Pricing Fragility

Upgrade to Reader to also access: Constraint Benefit Score, Obsolescence Risk Score

Third Party Analyst Consensus

12-Month Price Target

$20.25

Upgrade to Reader to also access: Bull Case, Base Case, Bear Case

Next Arc Research